Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- IL4 IL5 IL10 IL13 IL33 QPlex QView chemi-luminescent
- Product Overview:
Q-Plex™ Human Type 2 Immunity (5-Plex) is a quantitative chemiluminescent assay (ELISA) allowing for the detection of cytokines associated with type 2 immunity. Functions of type 2 immunity include protecting the host, maintaining metabolic homeostasis, and suppressing type 1 barrier defense, and tissue regeneration. Like other immune responses, excessive or chronic activation of type 2 immunity can be harmful to the host. Allergic disease, inability to defend against pathogens, and fibrosis have been described as harmful actions of type 2 immunity. Producers of type 2 cytokines include macrophages, mast cells, T cells, macrophages, monocytes, basophils, eosinophils, and natural killer cells. A variety of immune and non-immune cells have been noted to produce type 2 cytokine responses in response epithelial damage, release of alarmins, and antigen presentation/recognition. Q-Plex™ chemiluminescent assays require analysis via the Q-View™ imaging system. See Item No. 28264 for the Q-View™ Imager LS. Species: Human Sample Type: Human serum, EDTA/heparin plasma Volume Required per Well: 25 µl, minimum Assay Length: 2.25 hours Intra-assay Cross-reactivity: No significant interference observed. Assay Type:Sandwich Detection Method: Q-View™ Chemiluminescent Imaging System Item No. 28264 Multiplex Format: 96-well solid plate [QuanSys Catalog No. 114233HU]
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.